Oligometastatic disease at presentation or recurrence for nonsmall cell lung cancer

Pulmonary Medicine

Volumn , Issue , 2012, Pages

  Gomez, Daniel R ^a   Niibe, Yuzuru ^b   Chang, Joe Y ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOMYCIN; VINBLASTINE;

BRAIN METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LUNG NON SMALL CELL CANCER; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGOMETASTATIC DISEASE; PERSONALIZED MEDICINE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; STEREOTACTIC RADIOSURGERY;

EID: 84876075998     PISSN: 20901836     EISSN: 20901844     Source Type: Journal    
DOI: 10.1155/2012/396592     Document Type: Review

References (38)

1. Niibe Y., Hayakawa K., Oligometastases and oligo-recurrence: the new era of cancer therapy Japanese Journal of Clinical Oncology 2010 40 2 107 111
2. Hellman S., Weichselbaum R. R., Oligometastases Journal of Clinical Oncology 1995 13 1 8 10
3. Weichselbaum R. R., Hellman S., Oligometastases revisited Nature Reviews Clinical Oncology 2011 8 6 378 382
4. Gupta G. P., Massagué J., Cancer metastasis: building a framework Cell 2006 127 4 679 695 (Pubitemid 44781029)
5. Yachida S., Jones S., Bozic I., Antal T., Leary R., Fu B., Kamiyama M., Hruban R. H., Eshleman J. R., Nowak M. A., Velculescu V. E., Kinzler K. W., Vogelstein B., Iacobuzio-Donahue C. A., Distant metastasis occurs late during the genetic evolution of pancreatic cancer Nature 2010 467 7319 1114 1117
6. Hu C., Chang E. L., Hassenbusch S. J., Allen P. K., Woo S. Y., Mahajan A., Komaki R., Liao Z., Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis Cancer 2006 106 9 1998 2004 (Pubitemid 43673216)
7. Bonnette P., Puyo P., Gabriel C., Giudicelli R., Regnard J. F., Riquet M., Brichon P. Y., Surgical management of non-small cell lung cancer with synchronous brain metastases Chest 2001 119 5 1469 1475 (Pubitemid 32686031)
8. Rodrigues G., Eppinga W., Lagerwaard F., de Haan P., Haasbeek C., Perera F., Slotman B., Yaremko B., Yartsev S., Bauman G., A pooled analysis of arc-based image-guided simultaneous integrated boost radiation therapy for oligometastatic brain metastases Radiotherapy and Oncology 2011 102 2 180 186
9. Iwasaki A., Shirakusa T., Yoshinaga Y., Enatsu S., Yamamoto M., Evaluation of the treatment of non-small cell lung cancer with brain metastasis and the role of risk score as a survival predictor European Journal of Cardio-thoracic Surgery 2004 26 3 488 493 (Pubitemid 39091984)
10. Mussi A., Pistolesi M., Lucchi M., Janni A., Chella A., Parenti G., Rossi G., Angeletti C. A., Resection of single brain metastasis in non-small-cell lung cancer: prognostic factors Journal of Thoracic and Cardiovascular Surgery 1996 112 1 146 153 (Pubitemid 26268981)
11. Macchiarini P., Buonaguidi R., Hardin M., Mussi A., Angeletti C. A., Results and prognostic factors of surgery in the management of non-small cell lung with solitary brain metastasis Cancer 1991 68 2 300 304
12. Wronski M., Arbit E., Burt M., Galicich J. H., Survival after surgical treatment of brain metastases from lung cancer: a follow-up study of 231 patients treated between 1976 and 1991 Journal of Neurosurgery 1995 83 4 605 616
13. Martini N., Melamed M. R., Multiple primary lung cancers Journal of Thoracic and Cardiovascular Surgery 1975 70 4 606 612
14. Pfannschmidt J., Dienemann H., Surgical treatment of oligometastatic non-small cell lung cancer Lung Cancer 2010 69 3 251 258
15. Liu Y., Balter P., Komaki R., Xu Q., Swisher S., Chang J. Y., Stereotactc ablative radiotherapy for multiple primary lung cancer. International Journal of Radiation Oncology Biology Physics. In press
16. Niibe Y., Chang Y. J., Novel insights of oligometastases and oligorecurrence and review of the literatures. Pulmonary Medicine. In press
17. Niibe Y., Nishimura T., Inoue T., Karasawa K., Shioyama Y., Ogawa K., Takemoto M., Shirato H., Oligometastases of brain only in patients with non-small cell lung cancer (NSCLC) treated with stereotactic irradiation (STI): a multi-institutional study International Journal of Radiation Oncology Biology Physics 2010 78 supplement 3 S497
18. Tanvetyanon T., Robinson L. A., Schell M. J., Strong V. E., Kapoor R., Coit D. G., Bepler G., Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis Journal of Clinical Oncology 2008 26 7 1142 1147
19. Yano T., Haro A., Yoshida T., Morodomi Y., Ito K., Shikada Y., Shoji F., Maruyama R., Maehara Y., Prognostic impact of local treatment against postoperative oligometastases in non-small cell lung cancer Journal of Surgical Oncology 2010 102 7 852 855
20. Inoue T., Katoh N., Aoyama H., Onimaru R., Taguchi H., Onodera S., Yamaguchi S., Shirato H., Clinical outcomes of stereotactic brain and/or body radiotherapy for patients with oligometastatic lesions Japanese Journal of Clinical Oncology 2010 40 8 788 794
21. Hanagiri T., Sugaya M., Takenaka M., Oka S., Baba T., Shigematsu Y., Nagata Y., Shimokawa H., Uramoto H., Takenoyama M., Yasumoto K., Tanaka F., Preoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I non-small cell lung cancer Lung Cancer 2011 13 3 220 224
22. Guerra J. L. L., Gomez D., Zhuang Y., Hong D. S., Heymach J. V., Swisher S. G., Lin S. H., Komaki R., Cox J. D., Liao Z., Prognostic impact of radiation therapy to the primary tumor in patients with non-small cell lung cancer and oligometastasis at diagnosis. International Journal of Radiation Oncology Biology Physics. In press
23. Downey R. J., Ng K. K., Kris M. G., Bains M. S., Miller V. A., Heelan R., Bilsky M., Ginsberg R., Rusch V. W., A phase II trial of chemotherapy and surgery for non-small cell lung cancer patients with a synchronous solitary metastasis Lung Cancer 2002 38 2 193 197 (Pubitemid 35154384)
24. Liao S., Penney B. C., Zhang H., Suzuki K., Pu Y., Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer Academic Radiology 2012 19 1 69 77
25. Salama J. K., Chmura S. J., Mehta N., Yenice K. M., Stadler W. M., Vokes E. E., Haraf D., Hellman S., Weichselbaum R. R., An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease Clinical Cancer Research 2008 14 16 5255 5259
26. Hasselle M. D., Haraf D. J., Rusthoven K. E., Golden D. W., Salgia R., Villaflor V. M., Shah N., Hoffman P. C., Chmura S. J., Connell P. P., Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer Journal of Thoracic Oncology 2012 7 2 376 381
27. Salah S., Tanvetyanon T., Abbasi S., Metastatectomy for extra-cranial extra-adrenal non-small cell solitary metastases: systematic review and analysis of reported cases Lung Cancer 2012 75 1 9 14
28. Ambrogi V., Tonini G., Mineo T. C., Prolonged survival after extracranial metastasectomy from synchronous resectable lung cancer Annals of Surgical Oncology 2001 8 8 663 666 (Pubitemid 32847932)
29. Luketich J. D., Burt M. E., Does resection of adrenal metastases from non-small cell lung cancer improve survival? Annals of Thoracic Surgery 1996 62 6 1614 1616 (Pubitemid 26421089)
30. Luketich J. D., Martini N., Ginsberg R. J., Rigberg D., Burt M. E., Successful treatment of solitary extracranial metastases from non-small cell lung cancer Annals of Thoracic Surgery 1995 60 6 1609 1611
31. Porte H., Siat J., Guibert B., Lepimpec-Barthes F., Jancovici R., Bernard A., Foucart A., Wurtz A., Resection of adrenal metastases from non-small cell lung cancer: a multicenter study Annals of Thoracic Surgery 2001 71 3 981 985 (Pubitemid 32210414)
32. Mok T. S., Wu Y. L., Thongprasert S., Yang C. H., Chu D. T., Saijo N., Sunpaweravong P., Han B., Margono B., Ichinose Y., Nishiwaki Y., Ohe Y., Yang J. J., Chewaskulyong B., Jiang H., Duffield E. L., Watkins C. L., Armour A. A., Fukuoka M., Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma The New England Journal of Medicine 2009 361 10 947 957
33. Zhou C., Wu Y. L., Chen G., Feng J., Liu X. Q., Wang C., Zhang S., Wang J., Zhou S., Ren S., Lu S., Zhang L., Hu C., Hu C., Luo Y., Chen L., Ye M., Huang J., Zhi X., Zhang Y., Xiu Q., Ma J., Zhang L., You C., Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study The Lancet Oncology 2011 12 8 735 742
34. Camidge D. R., Doebele R. C., Treating ALK-positive lung cancer-early successes and future challenges Nature Reviews Clinical Oncology 2012 9 268 277
35. Sandler A., Gray R., Perry M. C., Brahmer J., Schiller J. H., Dowlati A., Lilenbaum R., Johnson D. H., Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer The New England Journal of Medicine 2006 355 24 2542 2550 (Pubitemid 44917502)
36. Paz-Ares L. G., Altug S., Vaury A. T., Jaime J. C., Russo F., Visseren-Grul C., PARAMOUNT: phase III study of maintenance pemetrexed plus best supportive care versus placebo plus best supportive care immediatly following induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small cell lung cancer Journal of Clinical Oncology 2011 29. (abstract CRA7510)
37. Cappuzzo F., Ciuleanu T., Stelmakh L., Cicenas S., Szczésna A., Juhsz E., Esteban E., Molinier O., Brugger W., Meleznek I., Klingelschmitt G., Klughammer B., Giaccone G., Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study The Lancet Oncology 2010 11 6 521 529
38. Ciuleanu T., Brodowicz T., Zielinski C., Kim J. H., Krzakowski M., Laack E., Wu Y. L., Bover I., Begbie S., Tzekova V., Cucevic B., Pereira J. R., Yang S. H., Madhavan J., Sugarman K. P., Peterson P., John W. J., Krejcy K., Belani C. P., Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study The Lancet 2009 374 9699 1432 1440